
Hussein Abkallo
Post Doctoral Fellow - Molecular Biology/Virology
Hussein Abkallo joined ILRI in August 2017 as a Post-Doctoral Fellow (Molecular Biology & Virology) with a remit to establish the cutting edge CRISPR/Cas9 technology for editing ASF virus genome, as well as the development of a reverse genetics system for generating synthetic ASF viral genomes, with a view to developing live attenuated vaccines (LAVs) against ASF virus. Hussein is a Biomedical Scientist who holds a PhD & MSc in Medical Sciences (Infections Research) from the Institute of Tropical Medicine, Nagasaki University, Japan and BSc Biomedical Sciences from Maseno University, Kenya. Before joining ILRI, he was a Royal Society Newton International Fellow at the University of Edinburgh in the UK where he was using CRISPR/Cas9 to edit P. falciparum genome. Hussein is keen on broader applications of CRISPR/Cas technology and Synthetic biology in developing vaccines and establishing ultra-sensitive diagnostics.
My Publications
Co-deletion of A238L and EP402R genes from a genotype IX African swine fever virus results in partial attenuation and protection in swine
Deletion of the CD2v gene from the genome of ASFV-Kenya-IX-1033 partially reduces virulence and induces protection in pigs

The African swine fever isolate ASFV-Kenya-IX-1033 is highly virulent and stable after propagation in the wild boar cell line WSL




